Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality

MLA

Rivinius R, et al. “Chronic Digitalis Therapy in Patients before Heart Transplantation Is an Independent Risk Factor for Increased Posttransplant Mortality.” Therapeutics and Clinical Risk Management, vol. ume 13, Oct. 2017, pp. 1399–407. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.20fd0295246149d987926f4a0abe61cc&authtype=sso&custid=ns315887.

APA

Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, & Doesch AO. (2017). Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality. Therapeutics and Clinical Risk Management, ume 13, 1399–1407.

Chicago

Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, and Doesch AO. 2017. “Chronic Digitalis Therapy in Patients before Heart Transplantation Is an Independent Risk Factor for Increased Posttransplant Mortality.” Therapeutics and Clinical Risk Management ume 13 (October): 1399–1407. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.20fd0295246149d987926f4a0abe61cc&authtype=sso&custid=ns315887.